A real world study of association of biomarker eosinophils and outcomes associated with omalizumab treated patients with allergic asthma
Latest Information Update: 07 Oct 2019
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Biomarker; Therapeutic Use
Most Recent Events
- 25 Sep 2019 Results assessing the association of biomarkers with real-world outcomes of Omalizumab treated patients with allergic asthma, published in the Clinical Therapeutics
- 18 Mar 2019 New trial record
- 25 Feb 2019 Results presented at the 2019 Annual Meeting of the American Academy of Allergy, Asthma and Immunology